Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Pieterman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|April 29, 2020
Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs <i>In Vitro</i>E D Pieterman, M J Sarink, C Sala, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2021
Higher Dosing of Rifamycins Does Not Increase Activity against Mycobacterium tuberculosis in the Hollow-Fiber Infection ModelE D Pieterman, S van den Berg, A van der Meijden, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
A multicentre verification study of the QuantiFERON<sup>®</sup>-TB Gold Plus assayE D Pieterman, F G Liqui Lung, A Verbon, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|April 29, 2020
Advanced Quantification Methods To Improve the 18b Dormancy Model for Assessing the Activity of Tuberculosis Drugs <i>In Vitro</i>E D Pieterman, M J Sarink, C Sala, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2021
Higher Dosing of Rifamycins Does Not Increase Activity against Mycobacterium tuberculosis in the Hollow-Fiber Infection ModelE D Pieterman, S van den Berg, A van der Meijden, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
A multicentre verification study of the QuantiFERON<sup>®</sup>-TB Gold Plus assayE D Pieterman, F G Liqui Lung, A Verbon, et al.
Pageof 1